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Tubular basement membrane changes in 2-amlno-4,5-diphenylthiazole-
induced polycystic disease. Polycystic renal disease was induced in rats
by feeding 2-amino-4,5-diphenylthiazole. Tubular (TBM) and glomeru-
lar basement membranes (GBM) were purified and analyzed for possi-
ble structural changes that may be a factor in the development of the
tubular dilations and cysts. Changes in the relative quantities of TBM
polypeptides were detected by sodium dodecylsulfate polyacrylamide
gel electrophoresis. An overall increase in the concentration of high
molecular weight components and a decrease in concentration of those
of low molecular weight components were observed. Changes which
were particularly notable included a twofold increase in a component of
Mr = 380,000 and a decrease in one of Mr = 55,000as analyzed without
reduction of disulfide bonds. With reduction of disulfide bonds, the Mr
= 380,000 component dissociates, whereas the Mr = 55,000polypeptide
does not, and polypeptides of Mr = 245,000 and 145,000 are observed to
increase about twofold in concentration (approximate molecular
weights were determined using globular protein standards). These
changes take place most rapidly from 4 to 8 weeks of drug administra-
tion and remain relatively constant between 8 and 16 weeks. If feeding
of the drug is discontinued, the distribution of TBM polypeptides
returns to normal. These results indicate that tubular basement mem-
brane from animals with 2-amino-4,5-diphenylthiazole-induced poly-
cystic renal disease is abnormal, and this should be considered as a
possible contributing factor in the formation of cysts.
Modifications de Ia membrane basale tubulaire au cours de Ia
polykystose induite par le 2.amino-4,5-diphénylthiazole. Une polykys-
tose rénale a été induite chez des rats en les nourrissant avec du
2-amino-4,5-diphénylthiazole. Les membranes basales tubulaires
(TBM) et glomérulaires (GBM) ont été purifiées et analysées a la
recherche de possibles modifications structurales qui pourraient être un
facteur de développement de dilatations et de kystes tubulaires. Les
modifications des quantités relatives des polypeptides des TBM ont été
détectées par électrophorèse sur gel de polyacrylamide avec du
dodécylsulfate de sodium. Une augmentation globale de Ia concentra-
tion des constituants de haut poids moléculaire et une baisse de la
concentration en constituants de faible poids moléculaire ont été
observées. Les changements qui était particulièrement notable
comprenaient une élévation de deux fois d'un constituant de Mr =
380.000 et une diminution d'un de Mr = 55.000, analyse sans reduction
des ponts disulfures. Aprés reduction des ponts disulfures, le constitu-
ant de Mr = 180.000 se dissocie, et non le polypeptide de Mr = 55.000,
et des polypeptides de M = 245.000 et 145.000 augmentent d'environ
deux fois en concentration (les poids moléculaires approximatifs ont etC
dCterminCs en utilisant des protéines globulaires standards). Ces mod-
ifications surviennent très rapidement aprCs 4 a 8 semaines
d'administration du mCdicament et restent relativement constantes
entre 8 et 16 semaines, Si l'administration du médicament est inter-
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rompue, Ia distribution des polypeptides IBM revient flia normale. Ces
rCsultats indiquent que des membranes basales tubulaires provenant
d'animaux atteints de polykystose rCnale induite par du 2-amino-4,5-
diphCnylthiazole sont anormales, et ceci pourrait être considérC comme
un facteur possible contribuant a la formation de kystes.
Human polycystic renal disease is characterized by massive
enlargements of the kidneys due to cysts which are scattered
throughout the parenchyma. Cysts develop from enlargements
of individual nephron segments of normal diameter. The cysts
can originate in various segments of the nephron wherein they
retain the transport functions characteristic of the segments
from which they are derived [1—3]. While the cause of cyst
formation remains unknown, one hypothesis suggests that it is
due to a prolonged increase in transmural pressure [4, 5]. A
second hypothesis suggests that cysts may form because of a
highly compliant basement membrane [61. Welling and Welling
[71 have concluded that neither hypothesis is uniquely consist-
ent with the available data, and cyst growth must depend on the
production of new epithelial cells and on the generation of new
tubular basement membrane (TBM). To date, the stimulus for
the change leading to cyst formation remains a mystery [8].
Cystic changes similar to the human disease have been
reported for several animal species [9—15]; however, none of
these has been adopted as a suitable model. Drug-induced
polycystic changes in animals have been used frequently as
models of the human disease. Among those that induce poly-
cystic changes and are well documented are diphenylamine [3,
16], 2-amino-4,5-diphenylthiazole HC1 (DPT) [6], nordihydro-
guaiaretic acid [17], and cisdiamine-dichloroplatinum II [18,
19]. The DPT-induced rat model of polycystic disease is partic-
ularly useful because the condition develops rapidly and it is a
diffuse condition, affecting most of the nephron.
In the DPT model, TBM becomes progressively thicker and
laminated with concomitant loss of alcian-blue staining [20].
Presumably, the loss of alcian-blue staining reflects changes in
the heparan sulfate proteoglycan component of the basement
membrane. When DPT treatment is discontinued, basement
membrane morphology and alcian-blue staining returns to nor-
mal [20].
The present study was undertaken to determine if other TBM
changes could be detected in DPT-induced cystic disease. The
results indicate that changes in the membrane occur in the form
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of altered relative quantities of apparently non-collagenous
polypeptides. This suggests that changes in the TBM, whether
they be primary or secondary to other effects, may be a
contributing factor in the increasing diameters of tubules in cyst
formation.
Methods
Male Sprague-Dawley rats weighing 150 to 200 g were used.
Two-amino-4,5-diphenylthiazole HC1 (DPT) was obtained from
Travenol Laboratories, Inc., Deerfield, Illinois, USA.
Disease induction
Rats were fed a diet containing 2% DPT ad libitum. Four
separate 8-week feeding experiments with 30 animals in each
group were conducted at different times. When changes were
documented from these studies, another feeding experiment
was done in which the progress of changes was followed in 10
animals each over a period of 16 weeks. As a part of the latter
experiment, one group of 10 animals was removed from drug
treatment after 8 weeks and sacrificed after 16 weeks to see if
the alterations were reversible [20]. Diseased kidneys and
controls were evaluated by light microscopy [6]. Kidneys were
fixed by arterial perfusion in 3% gluteraldehyde in modified
Tyrode's buffer containing 440 mOsm sodium chloride and 2%
dextran. The remaining kidneys were taken and frozen imme-
diately on dry ice.
Basement membranes
A flow diagram of the procedure used to obtain rat tubules
and glomeruli is shown in Figure 1. Cortical and medullary
tissue was dissected and placed in a 0.85% NaCl solution
containing 25 mM N-ethylmalamide, 25 mM ethylenediamine-
tetraacetic acid, and 20 ifiM e-aminocaproic acid to which 10
mM diisopropylphosphofluoridate was added just prior to use.
All of the purification steps were carried out at 4°C. Each
basement membrane preparation was done by processing 20
diseased and 20 control kidneys in parallel steps. Dissected
tissue was pressed through a 5-inch #60 sieve with a top of a
100 ml plastic syringe plunger, and the eluate was collected and
diluted to 250 ml. This material was further disrupted by
treatment with a Brinkman polytron using a 1 cm probe at 40%
of maximum power for 15 seconds in a volume of 250 ml. The
mixture was then passed over 100 and 250 mesh sieves. The
material retained by the 100 mesh sieve contained tubule
clusters and contaminating glomeruli. A second polytron treat-
ment was performed on this material to strip away the remain-
ing glomeruli and, if necessary, a third treatment was used. The
final product from the 100 mesh sieve represented the tubule
fraction. Glomeruli were obtained from the material originally
collected on the 250 mesh sieve. Tubules and glomeruli were
concentrated by centrifugation in a 40 ml polypropylene tube.
The pelleted material was diluted to 30 ml with 1 M NaC1
containing protease inhibitors. The pellets were suspended by a
brief polytron treatment, then cellular components were dis-
rupted by sonication. Sonication was done for 2 mm in 20-sec
bursts using a Heat Systems Biosonic 375 instrument equipped
with a microprobe. Following each 20-sec burst, the solutions
were allowed to cool to less than 8°C before additional sonica-
tion was done. Sonicated samples were passed over a 200 mesh
sieve to remove any undisrupted material and then collected by
centrifugation in a swinging bucket rotor at 2,000g [211. The
resulting pelleted TBM was washed twice in the 1 M NaC1
solution containing protease inhibitors and twice in distilled
water, and then lyophilized.
Electrophoretic analysis
Electrophoresis was performed in SDS using continuous
phosphate buffers [21] or discontinuous buffers [22]. Gels
consisted of either 6 or 3% polyacrylamide concentrations
[23—25].
Apparent molecular weights were based upon globular stan-
dards. Standard proteins included bovine serum albumin
(69,000), ovalbumin (45,000), carbonic anhydrase (29,000), beta
lactalbumin (18,400), and alpha lactalbumin (14,200). Calf skin
collagen was used to extend the useful range of the standard
curve. Molecular weights used for calf skin collagen were
133,000 for the alpha 1; 122,000 for the alpha 2 chain; 255,000
for the beta chains, and 380,000 for the gamma chain, consistent
with the apparent molecular weight of these chains when
compared to globular standards [25].
Basement membrane samples for electrophoresis were pre-
pared as described previously [23]. They were analyzed as
non-reduced whole membrane samples and as whole membrane
samples reduced with 4% mercaptoethanol at 90°C for 3 mm. In
addition, samples of SDS-soluble basement membrane were
obtained by extracting whole membrane with sample prepara-
tion buffer and removing the insoluble fraction [23]. The SDS-
insoluble fraction was then solubilized by reduction of disulfide
bonds and analyzed on three polyacrylamide gels.
Protein concentrations were determined by the Lowry pro-
cedure [26]. Samples containing mercaptoethanol were precip-
itated with 10 volumes of ethanol prior to protein determina-
tion. Amino acid analysis of basement membrane preparations
was performed on 24-hr hydrolysates using a Beckman 121 HP
analyzer [23].
Quantitation
Changes in polypeptides were quantitated from densitometer
scans of Coomassie blue-stained electrophoresis gels. Samples
of equivalent protein concentration from controls and cystic
TBM were applied to the gels. Areas under gel scans were
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Fig. 1. Protocol for preparation of rat tubules and glomeruli. Basement
membranes are prepared by sonication of the purified fractions, as
described in Methods.
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Table 1. Composition of rat basement membranes in chemically induced polycystic renal diseasea (residues/l000 standard deviation)
Amino Acid
CorticaI TBM Medullary TBM GBM
Control PC Control PCControl PC
3-Hydroxyproline 7.9 0.9 5.8 0,8 5.2 5.7 7.9 2.3 7.9 0.9
4-Hydroxyproline 65.3 1.1 73.3 1.1 62.9 75.4 67.8 4.3 65.4 2.2
Aspartic Acid 68.7 2.8 66.8 4.9 66.0 6.4.0 73.9 1.9 69.3 3.3
Senne 40.1 1.7 38.3 2.6 38.7 36.3 43.6 1.7 41.8 2.3
Threonine 57,3 2.2 55.5 2.7 55.3 52.5 59.2 2.3 57.2 3.2
Glutamic Acid 99,4 1.0 97.2 3.1 96.7 94.3 98.8 0.8 99.3 3.6
Proline 63.4 2.5 67.1 2.3 73.1 73.1 67.6 2.1 68.4 1.3
Glycine 222.0 5.8 233.4 5.9 228.2 240.9 200.0 1.8 202.8 3.9
Alanine 62.2 2.8 62.7 1.2 71.0 69.0 55.4 2.7 55.3 1.5
Valine 37,3 0.6 35.0 0.7 36.7 34.2 38.2 1.5 37.1 0.9
HaIf-cystine 17.9 2.6 18.9 3.4 17.5 15.0 27.5 2.9 28.3 1.8
Methionine 14.8 1.9 15.2 2.3 13.4 13.3 13.6 2.5 14.6 2.5
Isoleucine 27.9 1.5 26.4 1.3 25.8 25,4 27.7 3.1 26.6 3.1
Leucine 61.4 2.9 57.5 0.9 58.0 53.5 65.4 1.9 64.6 2.3
Tyrosine 18.5 1.1 17.1 0.7 16.8 15.8 18.7 2.2 19.2 2.3
Phenylalanine 28.5 0.4 28.5 0.1 26.6 30.2 30.3 4.1 31.3 3.0
Histidine 17.3 1.2 14.8 0.4 17.0 14.8 19.8 3.7 21.2 2.4
Hydroxylysine 19.4 1.5 21.1 0.1 17.3 18.1 21.8 0.3 21.7 2.0
Lysine 25.5 1.9 23.4 1.3 26.8 23.2 20.4 2.9 23.4 2.1
Arginine 45.0 1.0 43.1 2.7 49.3 45.8 43.4 3.2 45.7 1.7
a The amino acid compositions of cortical TBM and GBM are derived from analyses of preparations from three DPT feeding experiments. The
values for medullary TBM are an average from two DPT feeding experiments.
Abbreviation; PC, basement membranes from polycystic kidneys.
analyzing three different sample sizes covering a 3.3-fold pro-
tein concentration range.
Results were expressed as percent relative change = [(band
area — PKD)/(total area — PKD)]/[(band area — control)/(total
area — control)] x 100%, where band area corresponds to the
area under the gel scan from control or cystic (PKD) TBM.
Relative changes were also calculated by normalizing values to
the area of a band which is unchanged. The results obtained by
both methods were experimentally equivalent.
Results
TBM from DPT-induced PKD
Following administration of 2-amino-4,5-diphenylthiazole
HCI, thick sections of diseased kidneys were examined by light
microscopy to confirm that diffuse tubular cysts had developed
as described previously [6, 20]. Tubular and glomerular base-
ment membranes were prepared from the kidneys of control
groups and drug-treated groups so that their amino acid and
polypeptide compositions could be examined. Since this dis-
ease affects the cortical medullary collecting tubules first [6], it
was of interest to examine TBM both from the cortex and
medullas.
The protocol that was developed to prepare basement mem-
branes from rat kidneys is presented in Figure 1, and is
described in detail in Methods. This procedure differs from
other published methods for preparing rat TBM [27] in that a
polytron is used to disrupt tissues to permit more efficient
removal of glomeruli from the cortical tubules, and a medullary
tubule fraction is also obtained. Tubules from diseased kidneys
lose a large portion of their cells during processing, whereas
control tubules remain filled with their cellular constituents
prior to the sonication step. The glomeruli were stripped away
from the diseased tissue much more readily than from normal
tissue during the polytron treatment step, hence these prepara-
tions had almost no glomeruli, while control preparations
contained low levels of contaminating glomeruli.
The yield of cortical TBM was similar for preparations from
diseased animals (0.5 0.1 mg TBMlkidney) and controls (0.4
0.1 mg TBM/kidney). The yield of medullary TBM was about
one-third as much as cortical TBM and was also higher from
diseased kidneys (0.20 mg/kidney) than controls (0.15
mg/kidney). Tissue that could not be pressed through the 60
mesh sieve was worked up as a crude TBM fraction by
performing the polytron steps shown in Figure 1. The yield of
this material was 1.1 0.3 from diseased and 0.7 0.1 mg from
control kidneys. The yields reported here are based upon three
preparations each from control and diseased kidneys, using 20
kidneys per preparation.
Animal acid composition
The amino acid composition of representative basement
membrane preparations is given in Table 1. Overall, the com-
position of the various preparations is similar. The composition
of the control TBM is nearly identical with the diseased
membranes, with the exception of slightly elevated levels of
glycine, hydroxyproline, and hydroxylysine. An increase in
these amino acids suggests a small increase in the total collagen
content. The composition of the GBM is unchanged, consistent
with their apparent lack of involvement in the disease process.
Polypeptide composition
Sodium dodecylsulfate polyacryamide gel electrophoresis
was used to examine the polypeptide composition of TBM and
GBM from polycystic kidneys. The basement membranes were
divided into an SDS-soluble (soluble in SDS without reduction
of disulfide bonds), and SDS-insoluble fractions (this fraction
becomes soluble in SDS upon reduction). Comparisons were
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Fig. 2. Sodium dodecylsulfate polyac,ylamide gel electrophoresis analysis of TBM
and GBM from PKD and control rats under reducing conditions in 6% gel, Analysis
of TBM from PKD rats is shown in gel 1 and from control rats in gel 2. Analysis of
the GBM obtained from PKD kidneys is shown in gel 3 and from control kidneys in
gel 4. Gel S represents a protein standard consisting of type I collagen and
ovalbumin. Samples of GBM and cortical TBM were suspended in SDS sample
buffer and heated to 90CC for 3 mm. The soluble fraction was then reduced with
mercaptoethanol and samples corresponding to 90 tg of protein were applied to each
gel. Solid lines point to the polypeptides that consistently show the greatest increase
(145K band) or decrease (55K band) in the TBM from PKD kidneys. Lines pointing
to polypeptides with mobilities near the p chains of type I collagen indicate
polypeptides whose intensities increase in the TBM from PKD kidneys. These
polypeptides are resolved more effectively in the gel system shown in Figure 3. The
dashed line points to a polypeptide whose intensity changed in only two of four
experiments. Molecular weights were based upon globular protein standards as
described in Methods.
then made using the following samples: (1) SDS-soluble frac-
tion, non-reduced; (2) SDS-soluble fraction, reduced; (3) SDS-
insoluble fraction, reduced; and (4) unfractionated membrane
(whole membrane), reduced.
Figure 2 presents an analysis of an SDS-soluble, reduced
membrane fraction in 6% polyacrylamide gels. This fraction
appears to contain all of the TBM components except for type IV
collagen. Increases were detected in the relative amounts of higher
molecular weight polypeptides (< Mr = 100,000) in the TBM from
polycystic kidneys (the molecular weights of components were
determined from non-collagen standards). Several polypeptides in
particular were noted to be altered in relative intensity. Among
these, an increase in the concentration of a polypeptide(s) Of Mr
145,000 represents the most obvious change detected in this gel
system. Less significant increases could be seen in several
polypeptides whose mobilities are similar to the f3 chainsof type I
collagen. The latter changes were analyzed in another gel system,
as discussed below. A polypeptide of M 55,000 decreased
dramatically in concentration, whereas other low molecular
weight polypeptides (Mr < 100,000) decreased to a lesser degree
or not at all. The same changes in polypeptides of Mr = 145,000
and 55,000 are observed when whole TBM is analyzed under
reducing conditions in this gel system. Thus, they apparently are
not produced artilactually due to increased solubiity of these
components of the TBM from the diseased kidneys. Analysis of
reduced, whole TBM and of reduced, SDS-insoluble TBM (not
shown) showed no difference in the concentration of type IV
collagen monomer chains or their crosslinked multimers. The
GBM which was prepared from the same kidneys did not exhibit
the changes observed in TBM, except for a small decrease in
concentration of the Mr = 55,000 polypeptide (Fig. 2).
Changes were also seen in the TBM analyzed with disulfide
bonds intact in low percentage (3%) polyacrylamide gels. As
shown in Figure 3A, without reduction, all of the low molecular
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Fig. 3. Electrophoresis analysis in 3% gels of TBMfrom rats with drug-induced PKD. A Represents TBM with disulfide bonds intact. Samples
correspond to TBM from control rats (C), DPT-treated rats after 8 weeks (PC), and rats treated with DPT for 8 weeks followed by an 8 week
recovery period (R). Solid lines with molecular weights labeled in kilodaltons indicate components showing the greatest changes in concentration
in PKD. The component of Mr 55,000 apparently corresponds to the one indicated in the reduced sample in Figure 2. Lines without molecular
weights labeled indicate components whose concentrations increase to a relatively lesser extent. The arrow points to a Mr 130,000 band which
remains unchanged in intensity in non-reduced gel analysis. This band was used to normalize values for quantitative analysis (Fig. 4). Gel R
demonstrates that the relative concentrations of TBM components return to normal when DPT treatment is discontinued. B Represents analysis
of TBM samples as in A, but with disulfide bonds reduced. As in A, 3% polyacrylamide gels were run in continuous phosphate buffer to optimize
resolution of high molecular weight components. The top line indicates a Mr = 245,000 component which increases in intensity with DPT treatment(PC) and recovers upon removal of the drug (R). Other lines indicate components which show a lesser degree of change. A decrease in
concentration of low molecular weight components is evident in the PC sample; however, these components are not well resolved in this gel system
(see Fig. 2). C Represents analysis of SDS-soluble medullary TBM under reducing conditions in 6% gels with discontinuous buffers. Changes in
components of Mr = 55,000 and 145,000 correspond to those seen in cortical TBM (Fig. 2). The reversibility of these changes is evident in gel R.
Samples containing 180 g of protein were applied to the 3% gels (A and B) and 120 tg samples were applied to 6% gels (C).
weight components are somewhat decreased in concentration, but
the decrease is especially evident in the major, Mr 55,000
component. In contrast, a major component of Mr 130,000,
under non-reducing conditions, is unchanged in diseased corn-
pared to normal TBM. Larger components of Mr = 200,000 and
230,000 and one of Mr = 380,000are present in increased concen-
trations. With disulfide bonds intact, a large amount of material
remains on top of the gel so it is not accessible for analysis. The
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material which fails to penetrate the low percentage gel consists of
disuffide-bonded polypeptides since they dissociate and penetrate
the gels upon reduction, as analyzed in this gel system (Fig. 3B).
The use of 3% polyacrylamide gels under reducing conditions
permitted optimal resolution of polypeptides of Mr = 220,000,
230,000, and 245,000. Each of these polypeptides increases in
concentration in TBM from PKD rats. The Mr = 220,000 and
230,000 polypeptides appear to correspond to those also seen
before reduction, and the increase in their concentration in PKD,
while evident, is not dramatic. The Mr = 245,000 polypeptide
increases about twofold in concentration in PKD, and it appears
only after reduction.
Reversal of changes in TBM polypeptides
Experiments were performed to determine how early the
changes in TBM could be detected, and if they are reversible. In
these experiments, groups of ten animals each were examined
after 2, 4, 8, and 16 weeks of drug treatment, and both cortical
and medullary TBM were examined. Changes as described
above could be detected in both the cortical and medullary
TBM after 4 weeks of drug treatment, although at this stage
they were most obvious in the medullary TBM samples. It was
observed that with increasing age, the control TBM also
showed changes in the same direction as those seen in the TBM
from polycystic kidneys, but at a very much slower rate. It,
therefore, was important when quantitating the changes to
compare diseased membranes with their age-matched controls.
Figure 3A demonstrates the return to normal concentrations of
the high molecular weight components detected without reduc-
tion of disulfide bonds when drug treatment is discontinued. In
Figure 3B, it is seen that the components detected in 3% gels
upon reduction of disulfide bonds also return to normal concen-
trations upon removal of the drug. Analysis of reduced medul-
lary TBM samples in 6% gels is shown in Figure 3C. As with the
cortical TBM, changes in polypeptides of M = 55,000 and
145,000 are the most evident. Increases in other high molecular
weight polypeptides are also seen in the medullary TBM. These
appear to correspond to those described above in the cortical
TBM.
These changes were also reversed after drug treatment was
discontinued. In the experiment where animals were treated for
8 weeks, followed by an 8-week recovery period, the TBM
components appeared in nearly the same relative distribution as
in the untreated controls (Fig. 3C).
Quantitation of changes
Several of the TBM polypeptides that showed the greatest
changes, specifically, components of Mr = 380,000, 245,000,
and 55,000, were quantitated by scanning densitometry of SDS
gels, as described in Methods. Areas of specific components
were normalized with respect to total area and used to deter-
mine percent change. Alternatively, areas were normalized
with respect to a component that did not change in cystic TBM,
that is, in non-reduced gels where protein remains at the origin,
making quantitation of the total area difficult, areas were
normalized to the Mr = 130,000 component (Fig. 2B). The
results were approximately the same regardless of the method
used. Figure 4 shows the percent changes observed during the
16-week period for the M = 380,000 and 245,000 components
and their return to control values upon removal of DPT. The Mr
380,000 component is slightly decreased in intensity after 2
weeks; then, between 4 and 8 weeks, it increases to nearly
twice control values and thereafter remains constant. During
the recovery phase of the experiment, it returns to the control
level. The M = 245,000 polypeptide is elevated about 20% over
controls after 4 weeks of DPT treatment, then increases to
twice control levels by 8 weeks and thereafter remains con-
stant. The Mr = 55,000 polypeptide decreased (not shown)
steadily over the 16-week period and returns to control levels
when DPT treatment is discontinued.
Discussion
Renal basement membranes were purified from controls and
rats with DPT-induced polycystic renal disease in order to
compare them for possible structural differences. Modifications
of previously published preparation techniques [281 that were
introduced here, that is, the use of a polytron tissue disruptor,
provide for more efficient removal of glomeruli from tubule
fractions and permit the purification of both cortical and mcd-
ullary tubules. The yield of GBM was the same for polycystic
and control animals, whereas the yield of TBM from polycystic
kidneys was 20 to 30% higher than controls.
Reversible changes were detected in the TBM from the cystic
kidneys. There was a general decrease in concentration of low
molecular weight constituents of the TBM and a concomitant
increase in concentration of high molecular weight constituents.
Some of the changes were especially pronounced, including
approximately twofold increases in components of Mr
380,000, 245,000, and 145,000. The Mr = 380,000 component
dissociates upon reduction, while the Mr = 245,000 polypeptide
first appears upon reduction of disulfide bonds. A Mr = 145,000
polypeptide is present without reduction, but the dramatic
increase in its concentration is not seen until disulfide bonds are
reduced. This suggests that the latter is actually composed of
multiple polypeptides which have the same electrophoretic
mobility upon reduction. The increases in Mr = 245,000 and
145,000 polypeptides seen upon reduction appear to parallel
that of the non-reduced Mr = 380,000 component and the sum
of their approximate molecular weights is equal to 390,000.
Thus, it seems possible that they could be subunits of the Mr =
380,000 component.
The amino acid composition of TBM from cystic kidneys is
not very different from the controls, indicating that there is no
gross change in these membranes. Slight elevations in levels of
glycine, hydroxyproline, and hydroxylysine suggest some in-
crease in the total collagen content. Whether or not this
increase may be significant to the disease process cannot be
established until it is determined which collagen type(s) are
involved. As analyzed by gel electrophoresis, no major changes
were apparent in the type IV collagen fraction. There was a
slight increase in concentration of polypeptides, within the
SDS-soluble fraction, whose mobility corresponds to type IV
alpha chains. Within the SDS-insoluble fraction (which solubil-
izes upon reduction of disulfide bonds), there was no detectable
change in the concentration of type IV alpha chains. Type IV
collagen multimers also appeared to be normal in molecular
weight and concentration, suggesting that the aldehyde-derived







Gel electrophoresis analysis of the GBM indicated that
changes like those seen in TBM are not occurring in the cystic
kidneys. An exception to this was a slight decrease in concen-
tration of the Mr 55,000 polypeptide in GBM. This result is
consistent with the lack of involvement of the glomerulus in this
model.
In another study [20], DPT-induced structural changes were
observed in tubular cells and basement membranes of rat kidneys.
Structural changes in tubular cells consisted of increased SER and
free polyribosomes, elongation of RER, prominent Golgi com-
plexes, and increased numbers of lysosomes. TBM became thick-
ened and laminated with concomitant disappearance of alcian blue
and ruthenium red staining. Loss of alcian blue staining involved
all tubules, including those which were not cystic, but not
glomeruli. This finding suggests that there is a defect in the
metabolism of the proteoglycans of the TBM. Both tubular cells
and basement membranes returned to normal when DPT treat-
ment was discontinued.
In this study, we have demonstrated by chemical analysis
that alterations take place in the TBM of DPT-treated rats.
Additional studies will be required to identify the basement
membrane components that are involved. In view of the loss of
alcian blue staining in TBM from cystic kidneys [201, chemical
characterization of the proteoglycan is important. Antibodies to
the known basement membrane components could be useful
probes for characterizing the changes that take place. If the
altered components are unique to TBM, then it would be
necessary to isolate and biochemically characterize them to
understand their potential role in the disease process and their
function in the TBM.
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